The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapy.
Pchelina
Sofya N
SN
Saint-Petersburg Pavlov State Medical University, St. Petersburg, Russia; Petersburg Nuclear Physics Institute, St. Petersburg, Russia. sopchelina@hotmail.com
Sirotkina
Olga V
OV
Taraskina
Anastasiya E
AE
Vavilova
Tatyana V
TV
Shwarzman
Alexander L
AL
Schwartz
Eugene I
EI
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D015331:Cohort Studies; D065729:Cytochrome P-450 CYP2C9; D004305:Dose-Response Relationship, Drug; D005260:Female; D005787:Gene Frequency; D014644:Genetic Variation; D005828:Genetics, Population; D006720:Homozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D015995:Prevalence; D012426:Russia / Q000453:epidemiology; D013927:Thrombosis / Q000517:prevention & control; D014505:Urban Population; D014859:Warfarin / Q000627:therapeutic use*
D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases